Article

ICL suits low to high myopia, according to 3-year results

San Diego-The Implantable Collamer Lens (ICL, STAAR Surgical) appears to be safe and effective for treating low to high myopia based on the 3-year FDA study results. There is, however, a low risk of developing a cataract as a result of implantation, explained Harry Grabow, MD, who reported the findings at the annual meeting of the American Society of Cataract and Refractive Surgery.The criteria for inclusion in the myopic ICL study were –3 to –20 D of spherical equivalent (mean preoperative refraction, –10 D) and up to 2.5 D of cylinder. The refractive results were good with a mean stable postoperative refraction of about –0.5 D.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
© 2025 MJH Life Sciences

All rights reserved.